MedPath

Self-Guided Personalized Treatment for Women

Not Applicable
Not yet recruiting
Conditions
Disordered Eating
Interventions
Behavioral: Self-guided Personalized Treatment
Registration Number
NCT05920720
Lead Sponsor
University of Louisville
Brief Summary

The investigators plan to collect preliminary data on the feasibility, acceptability, and user uptake of a personalized self-guided mobile intervention for disordered eating (DE) and test the initial clinical efficacy of this intervention. Women (N=50) who endorse significant DE will complete two weeks of smart-phone self-monitoring to identify target problems and will be sent two self-guided modules of personalized treatment directly to their smart-phones. The investigators will assess engagement with the modules throughout two months and administer baseline, week 5, and week 8 assessments for acceptability, uptake, and initial clinical efficacy (e.g., DE symptoms, anxiety, quality of life). The investigators will also complete a focus group (n=10) with a subset of users to receive input on the mobile-application assessment and ease of self-guided intervention modules.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Endorse disordered eating (score of 2.3 or above on EDE-Q6)
  • Age 18-65
  • Ability to read and write English
  • Own a smartphone or tablet
Exclusion Criteria
  • Active mania
  • Active suicidality
  • Active psychosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Self-guided Personalized TreatmentSelf-guided Personalized TreatmentWomen who endorse significant DE will complete two weeks of smart-phone self-monitoring to identify target problems and will be sent two self-guided modules of personalized treatment directly to their smart-phones.
Primary Outcome Measures
NameTimeMethod
Clinical ImpairmentUp to 8 weeks

Changes in clinical impairment will be assessed with the Clinical Impairment Assessment (CIA)

AnxietyUp to 8 weeks

Changes in anxiety will be assessed with the Penn State Worry Questionnaire (PSWQ)

DepressionUp to 8 weeks

Changes in depression will be assessed with the Beck Depression Inventory-2 (BDI-2)

Disordered eating symptomsUp to 8 weeks

Changes in disordered eating symptoms will be assessed with the Eating Disorder Examination Questionnaire-6 (EDE-Q6)

Quality of lifeUp to 8 weeks

Changes in quality of life will be assessed with the Quality of Life Scale (QOLS)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Eating Anxiety Treatment Laboratory and Clinic

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath